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enetic and biochemical evidence demonstrated
that Eps8 is involved in the routing of signals from
Ras to Rac. This is achieved through the formation
of a tricomplex consisting of Eps8–E3b1–Sos-1, which is
endowed with Rac guanine nucleotide exchange activity.
 
The catalytic subunit of this complex is represented by Sos-1,
a bifunctional molecule capable of catalyzing guanine
nucleotide exchange on Ras and Rac. The mechanism by
which Sos-1 activity is speciﬁcally directed toward Rac re-
mains to be established. Here, by performing a structure–
function analysis we show that the Eps8 output function
resides in an effector region located within its COOH ter-
minus. This effector region, when separated from the ho-
G
 
loprotein, activates Rac and acts as a potent inducer of ac-
tin polymerization. In addition, it binds to Sos-1 and is able
to induce Rac-speciﬁc, Sos-1–dependent guanine nucle-
otide exchange activity. Finally, the Eps8 effector region
mediates a direct interaction of Eps8 with F-actin, dictating
Eps8 cellular localization. We propose a model whereby
 
the engagement of Eps8 in a tricomplex with E3b1 and
Sos-1 facilitates the interaction of Eps8 with Sos-1 and the
consequent activation of an Sos-1 Rac–speciﬁc catalytic
ability. In this complex, determinants of Eps8 are responsi-
ble for the proper localization of the Rac-activating ma-
chine to sites of actin remodeling.
 
Introduction
 
Small GTPases function as critical relays in the transduction
of signals originating from membrane receptors by cycling
between inactive GDP– and active GTP–bound states.
Guanine nucleotide exchange factors (GEFs)* catalyze the
exchange of GDP for GTP, thus controlling the rate and
timing of activation of small GTPases. The activation of re-
ceptor tyrosine kinases (RTKs), resulting in the reorganiza-
tion of the actin cytoskeleton, is one of the best character-
ized pathways controlled by these molecular switches. Active
ligand–engaged RTKs signal to a critical small GTPase, Ras,
which in turn activates another small GTPase, Rac. Finally,
active GTP–bound Rac is directly responsible for molecular
events leading to actin remodeling (for review see Bar-Sagi
and Hall, 2000; Scita et al., 2000).
The molecular mechanisms of this cascade are being eluci-
dated. Biochemical and genetic studies have shown how the
Son of Sevenless (Sos)-1 GEF transduces the signal from ac-
tive RTKs to Ras (for review see Bar-Sagi, 1994; Schles-
singer, 2000). Sos-1 interacts with the SH3-containing
adaptor molecule Grb2. Grb2 in turn displays an SH2 do-
main responsible for the recruitment of the Grb2–Sos-1
complex to active, autophosphorylated RTKs. The relocal-
ization of the complex to the plasma membrane is thought
to be sufficient for Sos-1 to catalyze the exchange of guanine
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nucleotides on Ras, which is also present at the plasma
membrane.
How Ras signals to Rac is less understood. Phosphatidyl-
inositol 3 kinase (PI3-K) binds directly to Ras-GTP and it is
required for activation of Rac (for review see Rodriguez-
Viciana et al., 1997). In hematopoietic cells, the product of
PI3-K’s catalytic activity, phosphatidylinositol 3,4,5 tris-
phosphate (PIP3), contributes through direct binding to the
activation of a Rac-specific GEF, Vav-1 (Han et al., 1998;
Das et al., 2000). In nonhematopoietic cells, the lack of ex-
pression of Vav-1 indicates that other GEFs must be in-
volved. Indeed, two recently identified members of the Vav
family, Vav2 and Vav3, display ubiquitous expression and
have been implicated in RTK-mediated actin remodelling
(Schuebel et al., 1998; Liu and Burridge, 2000; Moores et
al., 2000; Trenkle et al., 2000).
Sos-1 was also implicated in Ras-to-Rac signaling (Nim-
nual et al., 1998; Scita et al., 1999). Sos-1 was shown to par-
ticipate in vivo in a tricomplex with two signaling molecules,
Eps8 (Fazioli et al., 1993) and E3b1 (also known as Abi-1)
(Shi et al., 1995; Biesova et al., 1997). E3b1 contains an
SH3 domain that mediates its binding to Sos-1 (Scita et al.,
1999; Fan and Goff, 2000). In addition, E3b1 binds to the
SH3 domain of Eps8, thus acting as a scaffold protein which
holds together Sos-1 and Eps8 (Biesova et al., 1997; Mon-
giovi et al., 1999; Scita et al., 1999). The tricomplex Sos-1–
E3b1–Eps8 displays Rac GEF activity in vitro (Scita et al.,
1999). Therefore, Sos-1 might be endowed with a dual GEF
activity, for Ras and Rac, respectively. At the molecular
level, this is mirrored by the presence of two GEF domains
in Sos-1: (a) a Cdc25-like domain, responsible for activity
on Ras, and (b) a DH-PH tandem domain, a hallmark of
GEFs for Rho GTPases, the subfamily to which Rac be-
longs. However, purified Sos-1 does not display Rac-GEF
activity, whereas Ras-GEF activity could be readily detected.
Thus, a coherent picture of how Sos-1 regulates Rac activa-
tion is still missing. Another unresolved question concerns
the mechanism responsible for the proper compartmental-
ization of Sos-1 to sites where the Rac-based actin polymer-
izing machinery needs to be active. In this study, we provide
Figure 1. The COOH-terminal region 
(535–821) of Eps8 is necessary and 
sufficient for Eps8 localization to the 
cell cortex and its accumulation into 
PDGF-induced membrane ruffles. (A) 
Mouse embryo fibroblasts were serum 
starved for 24 h and then treated with 10 
ng/ml of PDGF ( PDGF) for 10 min or 
mock treated ( PDGF). Fibroblasts were 
fixed and stained with rhodamine-conju-
gated phalloidin (red, left) to detect 
F-actin or anti-Eps8 (green, right). 
Ruffling was detected in  90% of the 
PDGF-treated cells. (B) Mouse embryo 
fibroblasts were transfected with expres-
sion vectors encoding Eps8 full length or 
the indicated Eps8 fragments fused to 
GFP (FL, full length; amino acid bound-
aries of the other constructs are given in 
parentheses). After serum starvation, 
cells were treated with 10 ng/ml of 
PDGF ( PDGF) for 10 min or mock 
treated ( PDGF), followed by fixation 
and detection of GFP-Eps8 fusion pro-
teins by epifluorescence. Representative 
pictures are shown. In B, ruffles were 
identified by costaining with phalloidin 
(not shown). Arrowheads point to ruffles. 
Bars, 10  m. 
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evidence that Eps8 is a critical factor in the regulation of
both these functions.
 
Results
 
Identification of a COOH-terminal “effector region” of 
Eps8 capable of inducing actin polymerization
into ruffles
 
The biochemical function of Eps8, which mediates Ras to
Rac signaling, leading to actin cytoskeleton reorganization
(Scita et al., 1999, 2000), is mirrored by its subcellular local-
ization. In serum-starved fibroblasts, Eps8 displays a punctu-
ate, cytoplasmic perinuclear distribution with some staining
at the plasma membrane corresponding to sites of cortical
actin accumulation (Provenzano et al., 1998; Scita et al.,
1999; Fig. 1 A). A substantial relocalization of Eps8 occurs
upon treatment with growth factors within sites of actin po-
lymerization, at the dorsal surface of cells, and in membrane
ruffles (Provenzano et al., 1998; Scita et al., 1999; Fig. 1 A).
To identify the region of Eps8 that mediates its localiza-
tion, we used deletion mutants of Eps8 fused to the green
fluorescence protein (GFP). A GFP full length Eps8 (amino
acids 1–821) displayed a sub-cellular localization indistin-
guishable from that of the endogenous protein (Fig. 1 B). In
contrast, a NH
 
2
 
-terminal fragment (amino acids 1–535)
showed a diffuse cytoplasmic and nuclear staining unaltered
by treatment with growth factors, suggesting that the
COOH terminus contains residues important for Eps8 lo-
calization (Fig. 1 B). Accordingly, a COOH-terminal frag-
ment (amino acids 535–821) displayed intense localization
along the cell cortex within structures reminiscent of ruffles.
These structures corresponded to sites of actin polymeriza-
tion (not shown; see also Fig. 2). The differential cellular lo-
calization of the Eps8 mutants was not due to the GFP moi-
ety, since GFP alone was diffusely distributed in the nucleus
and the cytoplasm (not shown). Furthermore, similar levels
of expression of the various Eps8 constructs were obtained,
as determined by immunoblotting (not shown) and immun-
ofluorescence analysis (Fig. 1 B). Thus, our data indicate
that determinants in the COOH terminus are responsible
for the subcellular localization of Eps8.
An unexpected finding emerged from the studies with the
Eps8 (535–821) mutant. In serum-starved mouse embryo fi-
broblasts, where the actin cytoskeleton is organized in a flat
array of stress fibers, the expression of this mutant caused re-
organization of F-actin into dorsal and membrane ruffles
(Fig. 2 B). This effect could also be observed in different cell
lines (Cos-7, NIH-3T3, HeLa; not shown). Thus, the
COOH terminus of Eps8 is responsible not only for proper
localization of the protein, but it also displays an “effector”
function, capable of inducing actin cytoskeleton remodeling
in the absence of growth factor stimulation.
 
Mapping of the effector region of Eps8
 
We engineered a series of deletion mutants of Eps8 (Fig. 2
A) fused to GFP. A mutant, 586–821, lacking the SH3 do-
Figure 2. Identification of the minimal effector region of Eps8 
capable of inducing actin polymerization into ruffles. (A) Sche-
matic of the various Eps8 fragments, all engineered as GFP fusion 
proteins (amino acid boundaries are given on the left of the con-
structs. The SH3 domain is indicated by a solid box), and their bio-
logical characterization. Mouse embryo fibroblasts, transfected 
with the indicated GFP-tagged expression vectors, were serum 
starved and treated with 10 ng/ml of PDGF for 10 min ( PDGF) or 
mock treated ( PDGF). Cells were then fixed for subsequent 
detection of GFP by epifluorescence and F-actin by rhodamine-
conjugated phalloidin. (B) Mouse embryo fibroblasts, transfected 
with the indicated expression vectors, were serum-starved and 
fixed for subsequent detection of GFP by epifluorescence (green), 
and F-actin by rhodamine-conjugated phalloidin (red). Actin poly-
merization into ruffles induced by the biologically active Eps8 frag-
ments was detected in  80% of the transfected cells. The effect of 
selected constructs is shown. Arrows point to ruffles. Bar, 10  m. 
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main retained ruffling activity in the absence of growth fac-
tor treatment (Fig. 2, A and B), indicating that the SH3 do-
main of Eps8 is dispensable for actin reorganization activity
in the absence of growth factors. Thus, an interaction with
E3b1, mediated by the SH3 domain of Eps8, is not required
for the effector function of the COOH-terminal fragment of
Eps8.
Further deletions of the COOH terminus of Eps8 (Fig. 2,
A and B) showed that the minimal region required to elicit
ruffling spanned amino acids 648–821. Interestingly, this
region is also the minimal region required for colocalization
with polymerized actin (Fig. 2 A). Indeed, for all the Eps8
mutants containing this region, there was perfect correlation
between ruffling activity and colocalization with phalloidin-
stained F-actin (or lack of both events; Fig. 2 A). Notably,
the Eps8 effector region, similarly to the known inducer of
actin polymerization such as activated Rac and PI3-K, in-
duces prominent peripheral ruffles, but only rarely circular
ruffles. These latter structures are dependent on PDGF
stimulation, pointing to the requirement of additional sig-
naling events, whose nature remains undetermined.
The ruffle-inducing activity of the Eps8 effector region
was recorded in real time. The GFP effector region of Eps8
(586–821) rapidly induced and accumulated within dy-
namic structures along the dorsal area and the leading edge
of cells, thus confirming the observations obtained in para-
formaldehyde-fixed cells. Furthermore, it relocalized in pro-
truding lamellipodia of spreading and moving cells, suggest-
ing its involvement in migratory processes (supplementary
information). Thus, Eps8 is endowed with a potent and con-
stitutive ruffle-inducing activity residing in its 173 COOH-
terminal amino acids.
 
Signaling by the effector region of Eps8
 
Ras and Rho GTPases establish a signaling network that reg-
ulates actin rearrangement (for review see Bar-Sagi and Hall,
2000; Scita et al., 2000), a process in which the participation
of PI3-K has also been firmly established (for review see
 
immunocomplex kinase assays using myelin basic protein (MBP) as a 
substrate. An aliquot of the immunoprecipitates was also immunoblot-
ted with anti-MAPK antibodies (MAPK). The doublet MAPK band, 
detected in the EGF-treated control sample, represents the active 
phosphorylated form. (B) Mouse embryo fibroblasts were cotrans-
fected with expression vectors encoding a dominant negative HA-
tagged Cdc42 (Cdc42N17) or an empty vector as a control (Ctr) 
together with pCDNA-HA-JNK, serum starved for 24 h, and treated 
with 100 ng/ml of EGF (
 
 
 
) or mock treated for 10 min (
 
 
 
). JNK kinase 
activity was determined in immunocomplex kinase assays, using the 
COOH-terminal region of c-JUN (Jun79) as a substrate. An aliquot of 
the immunoprecipitates was also immunoblotted with anti-JNK anti-
bodies (JNK). The expression of RasN17 in A and HA-Cdc42N17 in B 
was determined by immunoblot analysis with anti-Ras and anti-HA 
antibodies, respectively (not shown). (C–E). Nuclei of quiescent 
mouse embryo fibroblasts were microinjected with expression vec-
tors encoding RhoN19 (C), RacN17 (D), or p85
 
 
 
iSH2 (E). After 3 h, 
cells were stimulated with either 10% serum for 60 min (C) or
PDGF (10 ng/ml) for 10 min (D and E) and fixed and stained with 
rhodamine-conjugated phalloidin (red) to detect F-actin, anti-Rho 
(C, green), anti-Rac (D, green) or anti-p85 (E, green) antibodies. (F) 
Quiescent mouse embryo fibroblasts were treated with wortmannin 
(100 nM) (
 
 
 
Wrt) or vehicle as a control (
 
 
 
Wrt) for 1 h before adding 
PDGF for 10 min. Cells were then fixed and stained with phalloidin 
(red). Arrows point to ruffles. Bar, 10 
 
 
 
m.
Figure 3.
 
Expression and biological activity of dominant negative 
mutants of Ras, Cdc42, Rho, Rac, PI-3K, and of the PI-3K inhibitor, 
wortmannin.
 
 (A) Mouse embryo fibroblasts were cotransfected with 
an expression vector encoding RasN17 (Ras N17) or an empty vector 
as a control (Ctr), together with pCDNA-HA-MAPK. Cells were serum 
starved for 24 h and treated with 100 ng/ml of EGF (
 
 
 
) or mock 
treated (
 
 
 
) for 10 min. MAPK kinase activity was determined in  
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Rodriguez-Viciana et al., 1997). To define the site of action
of the effector region of Eps8 in the signaling pathways lead-
ing to actin remodeling, we attempted to interfere with its
function with a series of molecular and pharmacological in-
hibitors. In particular, we used dominant negative versions
of Ras (RasN17), Cdc42 (Cdc42N17), Rho (RhoN19),
PI3-K (p85
 
 
 
iSH2), and Rac (586-821). We also used the
PI3-K–specific inhibitor, wortmannin.
Upon microinjection in mouse fibroblasts, all the domi-
nant negative mutants were readily expressed (Fig. 3) and bi-
ologically active, as shown by the ability of: (a) RasN17
to inhibit EGF-induced mitogen-activated protein kinase
(MAPK) activation (Fig. 3 A); (b) Cdc42N17 to reduce
growth factor–induced JNK activity (Fig. 3 B); (c) RhoN19
to inhibit the formation of serum-induced stress fibers (Fig.
3 C); and (d) RacN17 (Fig. 3 D) and p85
 
 
 
iSH2 (Fig. 3
E) to inhibit PDGF-mediated actin cytoskeleton reorgan-
ization. Wortmannin also abrogated completely PDGF-
induced actin remodeling (Fig. 3 F).
We then attempted to interfere with the ruffling activity
of GFP-Eps8 (648–821) by comicroinjecting the dominant
negative mutants or by treating cells microinjected with this
latter construct with wortmannin. Ruffling activity was un-
affected by coexpression of dominant negative Ras, Cdc42,
Rho, or PI3-K, or by treatment with wortmannin (Fig. 4).
Figure 4. The effector region of Eps8 requires Rac for its actin re-
modelling activity. Nuclei of quiescent mouse embryo fibroblasts 
were comicroinjected with the expression vector for GFP-Eps8 
(648–821) (all panels) together with one of the indicated (left) domi-
nant negative mutants (ctr, comicroinjection with control vector). In 
the bottom panels (Wrt), microinjection was with GFP-Eps8 
(648–821) alone followed by treatment with wortmannin for 60 
min. After 3 h, cells were fixed and detection of GFP was performed 
by epifluorescence (green), whereas F-actin was detected by phal-
loidin staining (red). All the comicroinjected cells expressed the 
GFP-Eps8 (648–821) fragment and the individual dominant negative 
mutant, as determined in parallel experiments, by directly staining 
the microinjected cells with antibodies specific to the various domi-
nant negative mutants (not shown). More than 100 injected cells 
were analyzed in each experiment. Similar results were obtained in 
transfection experiments. Arrows point to ruffles. Bar, 10  m.
Figure 5. A dominant negative Arf6 mutant inhibits ruffling in-
duced by GFP-Eps8 (648–821). (A) Nuclei of quiescent mouse 
embryo fibroblasts were microinjected with the expression vector 
encoding a dominant negative Arf6 (Arf6T27N). After 3 h cells were 
stimulated with PDGF (10 ng/ml) for 10 min, and then fixed and 
stained with FITC-conjugated phalloidin (green) to detect F-actin 
and with the anti-myc antibody to detect Arf6T27N (red). Arf6T27N 
inhibited PDGF-induced ruffling in 90   4% (mean   SE) of the 
injected cells, as compared with cells injected with an empty vec-
tor. (B) Nuclei of quiescent mouse embryo fibroblasts were microin-
jected with expression vectors for GFP-Eps8 (648–821) (all panels) 
together with either a control vector (ctr) or a vector encoding myc-
Arf6T27N (Arf6T27N). After 3 h, cells were fixed and detection of 
GFP was performed by epifluorescence (green). Phalloidin (red) 
staining was also performed. All the comicroinjected cells 
expressed both the GFP-Eps8 (648–821) fragment and the Arf6T27N 
mutant, as determined in parallel experiments by directly staining 
the microinjected cells with anti-myc antibodies to detect Arf6T27N 
(not shown). More than 100 injected cells were analyzed in each 
experiment. Similar results were obtained in transfection experi-
ments. Arrows point to ruffles. Bars, 10  m. 
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However, the expression of a dominant negative Rac abro-
gated the GFP-Eps8 (648–821)–induced ruffles (Fig. 4).
Thus, the ruffling activity of the effector region of Eps8 is
apparently exerted at a step upstream of Rac and does not re-
quire the functions of Ras and PI3-K.
The dependence on Rac activity of the effect of GFP-Eps8
(648–821) was further supported by experiments performed
with a dominant negative Arf6 mutant. Arf6 is a protein be-
longing to the Arf subfamily of small GTPases (Donaldson
and Radhakrishna, 2001). A dominant negative Arf6 blocks
Rac-dependent actin reorganization, likely by preventing the
translocation of GTP-bound Rac from an endosomal com-
partment to the plasma membrane (Radhakrishna et al.,
1999; Zhang et al., 1999; Fig. 5 A). Microinjection, in
mouse fibroblasts, of a dominant negative mutant Arf6
(Arf6T27N) capable of abrogating Rac-dependent PDGF-
induced ruffles inhibited GFP-Eps8 (648–821)–dependent
actin cytoskeleton rearrangement (Fig. 5 B), compatible
with the requirement for proper localization of Rac.
 
The effector region of Eps8 activates Rac and
Rac-dependent pathways, binds to Sos-1, and 
stimulates Rac-specific, Sos-1–dependent GEF activity
 
The Rac-dependent ruffling activity of the effector region of
Eps8 suggests that it may act by activating Rac. Thus, we
tested the ability of the 648–821 region of Eps8 to induce
the activation of Rac and of PAK65, a direct downstream ef-
fector of Rac (for review see Lim et al., 1996). As shown in
Fig. 6 A, the expression in quiescent fibroblasts of GFP-
Eps8 (648–821), but not of GFP or GFP-Eps8 (586–701),
increased the levels of activated GTP-bound Rac. This was
mirrored by the activation of PAK65 to levels similar to
those induced by a constitutively active Rac mutant. These
results indicate that the effector region of Eps8 activates Rac
in vivo.
Therefore, the effector region of Eps8 seems to recapitu-
late the physiological function of Eps8, behaving as a domi-
nant active mutant and bypassing the need for growth factor
stimulation. However, at variance with Eps8, the effector re-
gion does not require a physical interaction with E3b1 (Figs.
2, and 7, A and C) and the ensuing formation of a trimeric
complex with Sos-1. On the other hand, the COOH termi-
nus of Eps8 has been shown to bind in vitro to Sos-1 inde-
pendently of E3b1 (Scita et al., 1999), albeit with low
stoichiometry. Thus, this interaction may be sufficient to
elicit Sos-1 guanine nucleotide exchange activity, leading to
the activation of Rac in vivo.
To test this possibility, we first mapped the region of
Eps8 that binds to Sos-1. Native Sos-1 could be specifically
recovered onto GST-fused Eps8 COOH-terminal frag-
Figure 6. The effector region of Eps8 activates Rac and Rac-
dependent biochemical pathways. (A) The expression vectors indi-
cated on the top, and encoding GFP-Eps8 (648–821), GFP-Eps8 
(586–701), GFP, and HA-Rac were transfected, alone or in combi-
nation, into mouse embryo fibroblasts. After 24 h of serum depriva-
tion, Rac-GTP levels were determined by an in vitro binding assay 
using the CRIB domain of PAK65 fused to GST (top). Aliquots of the 
lysates were also analyzed for the expression of the GFP or the GFP-
tagged Eps8 fragments and of HA-Rac by direct immunoblot (bot-
tom). (B) Mouse embryo fibroblasts were cotransfected with expres-
sion vectors for HA-PAK65 together with the indicated (top) GFP-
tagged Eps8 fragments (1–535 or 648–821), an activated Rac mutant 
(RacQL), or an empty vector as a control (ctr). After 24 h of serum 
deprivation, PAK65 kinase activity was determined by immuno-
complex kinase assays using MBP as a substrate (MBP). An aliquot 
of the immunoprecipitates used for each kinase assay was immuno-
blotted with anti-HA to detect PAK65 (PAK65). Aliquots of the ly-
sates were also analyzed for the expression of the GFP-tagged Eps8 
fragments and of RacQL by direct immunoblot (GFP and RacQL).
 
Figure 7.
 
The Eps8 effector region binds to Sos-1 and stimulates Rac-specific, Sos-1–dependent GEF activity.
 
 (A) Total cellular lysates from 
Cos-7 cells were incubated with 5 
 
 
 
g of each Eps8 fragment (all engineered as GST fusions; amino acid boundaries are indicated at the top) 
or GST as a negative control, or GST-E3b1 as a positive control (Scita et al., 1999). Detection was with anti–Sos-1 Ab. The lane “lysate” was 
loaded with 50 
 
 
 
g of total cellular lysate. (B) Left, eukaryotically produced, affinity-purified Sos-1 was resolved by SDS-PAGE and stained 
with Coomassie brilliant blue. Sos-1 was estimated to be 
 
 
 
90% pure (see Materials and methods). Right, purified Sos-1 (1 
 
 
 
g) was incubated 
with 5 
 
 
 
g of the indicated GST fusion proteins (all Eps8 fragments; amino acids boundaries are indicated on the top). Detection was with 
anti–Sos-1 Ab. The binding of Sos-1 to full length Eps8 (1–821) was estimated to be 
 
 
 
10 less than the binding to GST-Eps8 (586–821) or GST-
Eps8 (648–821) by densitometric analysis. (C) Lysates of 293T cells transfected with the indicated cDNAs (tfx) were immunoprecipitated (IP) 
with anti-Eps8 (Eps8) or anti-HA (HA), or the corresponding preimmune sera (ctr) followed by detection (Western blot, WB) with anti–Sos-1, 
anti-Eps8, anti-E3b1, or anti-HA antibodies. Native Sos-1 could also be recovered in immunoprecipitates of the Eps8 fragments 648–821 (not  
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shown). The lanes “lysate” were loaded with 50 
 
 
 
g of total cellular lysates. (D) Top, Rac-specific GEF activity was measured in lysates of cells 
expressing the indicated Eps8 fragments (indicated underneath the bar graph. Ctr, control vector). Lysates were immunodepleted with an 
irrelevant (mock ID, solid bars) or by an anti–Sos-1 (Sos-1 ID, empty bars) antibody. The same immunodepleted lysates used for the GEF 
assays were analyzed by immunoblotting (WB, bottom) with the indicated antibodies. No Cdc42-specific GEF activity could be detected in 
the same lysates (not shown). (E) Top, Rac-specific GEF activity was measured in immunoprecipitates performed with anti-HA (IP HA) or an 
irrelevant antibody (IP ctr) on lysates of 293T cells transfected with the indicated expression vectors (tfx; the Eps8-based constructs were HA 
tagged). Bottom, aliquots of the immunoprecipitates (IP) used in the GEF assay, or total cellular lysates (50 
 
 
 
g) transfected with the expression 
vectors indicated at the bottom (tfx), were immunoblotted (WB) with the indicated antibodies. 
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ments. The minimal region capable of interacting with
Sos-1 extended from amino acids 648 to 821, thus coincid-
ing with the region required for the biological activity of
the effector domain (Fig. 7, A and B). The interaction was
likely direct, since GST-Eps8 (648–821) was able to bind,
albeit with low stoichiometry, to native, eukaryotically
produced, and purified (
 
 
 
90% purity) Sos-1 (Fig. 6 C).
However, it cannot be formally excluded that copurified
proteins tightly associated to Sos-1 might be responsible
for the observed interaction.
As shown in Fig. 7 B, the effector region of Eps8, when
alone, bound to purified Sos-1 at least 10-fold better than
full length GST-Eps8. The marginal binding of full length
GST-Eps8 might reflect the true ability of the holoprotein
to interact with Sos-1 or an artifactual situation. Under this
latter scenario, one could postulate that in vivo Eps8 does
not bind to Sos-1 unless determinants in its COOH termi-
nus are unmasked: a setting mimicked by the enucleation of
the effector region from the holoprotein, or by partial un-
folding of the bacterially expressed Eps8 full length mole-
cule. To gain insight into this issue we studied the associa-
tion in vivo of Sos-1 with either the effector region of Eps8
or with the holoprotein. Native Sos-1 could be efficiently re-
covered in HA-tagged Eps8 (586–821) immunoprecipitates
of cells double transfected with Sos-1 and HA-Eps8 (586–
821) (Fig. 7 C). No E3b1 could be detected in the same
immunoprecipitates, even under conditions of E3b1 overex-
pression (not shown). On the contrary, the in vivo
 
 
 
associa-
tion between Sos-1 and Eps8 was strictly E3b1-dependent.
Indeed, native Sos-1 could be readily recovered in Eps8 im-
munoprecipitates from triple Sos-1–E3b1–Eps8 transfec-
tants, but not when an Eps8 mutant, unable to bind E3b1
due to a deletion in its SH3 domain (Eps8
 
 
 
SH3), was used
(Sos-1–Eps8
 
 
 
SH3–E3b1 transfectants), or when E3b1 was
not transfected along with Sos-1 and Eps8 (Sos-1–Eps8)
(Scita et al., 1999; Fig. 7 C).
We then tested whether the biological and biochemical
activity of the Eps8 effector region could activate Sos-1 Rac–
specific GEF in vivo. First, a Rac-GEF assay was performed
using lysates of cells expressing the effector domain of Eps8
or a ruffling-incompetent Eps8 fragment (586–733) which
cannot bind to Sos-1. Expression of the effector region, but
not of the ruffling-incompetent fragment, induced a sub-
stantial increase in Rac-specific GEF activity in vivo over the
basal control values (Fig. 7 D). This effect was dependent on
the presence of Sos-1 (or of another GEF, tightly associated
to Sos-1), since no Rac-GEF activity could be detected in
the same lysates upon immunodepletion of Sos-1 (Fig. 7 D).
Second, we used in vitro assays that can score GEF activities
in immunoprecipitates. Cells were transfected either with a
construct containing the effector region, Eps8 (586–821), or
with a control construct, Eps8 (1–535), alone or in combi-
nation with Sos-1. Rac-GEF activity could be readily de-
tected when the Eps8 (586–821) protein was immunopre-
cipitated from cells coexpressing Eps8 (586–821) and Sos-1
(Fig. 7 E). Under these conditions, coimmunoprecipitation
between Eps8 (586–821) and Sos-1 was detected (Fig. 7 E,
bottom). Thus, the Eps8 effector region participates in the
regulation of a Rac-specific GEF activity, which depends on
the presence of Sos-1 or Sos-1–associated GEFs.
Figure 8. Identification by MALDI-MS of novel interactors of the 
effector domain of Eps8. (A) Various immobilized GST fusion frag-
ments of the COOH-terminal region of Eps8 (amino acid boundaries 
are indicated on the top), GST-SH3 domain of Eps8 (SH3), or GST 
alone were incubated in the presence of lysis buffer as a control or with 
total cellular lysates ( lysates lanes) from mouse embryo fibroblasts. 
Specifically bound proteins were eluted in sample buffer and resolved 
by SDS-PAGE, followed by detection by silver staining. The marked (as-
terisk and arrowhead) bands were unequivocally identified by MALDI-
MS, as described in Materials and methods, as the myosin II heavy 
chain and actin, respectively. Molecular weight markers are indicated 
in kD. (B) Total cellular lysates (1 mg) from mouse embryo fibroblasts 
were incubated with 5  g of GST or GST-Eps8 (586–821). Detection 
was with antimyosin II heavy chain and antiactin antibodies as shown. 
The lane “lysate” was loaded with 100  g of total cellular lysate. 
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Eps8 interaction with F-actin, through its effector 
domain, directs its localization to site of
actin remodeling
 
The effector domain of Eps8 was also responsible for its lo-
calization within F-actin–containing structures (Fig. 2 A).
Thus, we looked for interactors with the Eps8 effector re-
gion. We used various GST-fused fragments of Eps8 in or-
der to specifically recover proteins from cell lysates. As
shown in Fig. 8 A, several cellular proteins were detected by
silver staining. We concentrated our attention on those
bands that were recovered by the 586–821 fragment (which
is biologically active and properly localized), but not by the
733–821 or by the SH3 fragments (which are biologically
inactive and delocalized), and subjected them to MALDI
mass spectrometry and NanoElectrospray. Two proteins
were unequivocally identified: actin and the myosin II heavy
chain (Fig. 8 A). Both associations were confirmed by in
vitro binding experiments (Fig. 8 B). Of note, the low stoi-
chiometry of interaction between Eps8 and myosin II heavy
chain suggested an indirect interaction, possibly mediated by
actin. Therefore, we characterized the Eps8/actin associa-
tion.
We mapped the minimal interaction surface of Eps8 with
actin to a stretch of amino acids extending from position
648 to 821 (Fig. 9 A). Notably, this actin binding domain
coincided with the minimal region required to elicit ruffling,
bind to Sos-1, and colocalize with F-actin. Attempts to de-
fine determinants within this region individually responsible
Figure 9. Biochemical characterization 
of the interaction between the Eps8 and 
actin. (A) Total cellular lysates from 
mouse embryo fibroblasts were incubated 
with 5  g of each Eps8 fragment (all engi-
neered as GST fusions; amino acid 
boundaries are indicated on the top) or 
GST or GST-E3b1, used as negative con-
trols. Detection was with antiactin anti-
bodies. The lane “lysate” was loaded with 
50  g of total cellular lysate. (B) Actin 
cosedimentation assay. The indicated 
fragments of Eps8 (left, Eps8 [733–821]; 
right, Eps8 [586–821]) fused to GST (2 
 g) were mixed with increasing amounts 
of F-actin (0.5, 1.0, 2.0, and 10  g, 
respectively), as described in Materials 
and methods, and the samples were ultra-
centrifuged. The input lanes (inp) show 
the supernatant (S) and the pellet (P) of a 
control tube, in which the GST fusion 
proteins were subjected to ultracentrifu-
gation in the absence of F-actin. Detec-
tion was with anti-GST (top) or antiactin 
(bottom). (C) Purified, globular, nonmus-
cle actin (2  g) was incubated with 5  g 
of Sepharose-conjugated GST as a nega-
tive control, or GST-Scar-2-WA-domain 
(Scar2-WA) as a positive control (left; 
Miki et al., 1998), or GST-Eps8 fragments 
(amino acid boundaries are indicated in 
the top right panels). Bound proteins were 
recovered by low speed centrifugation 
and analyzed by immunoblotting (WB) 
with antiactin (Actin) and anti-GST (GST) 
antibodies. The lane “input” was loaded 
with 100 ng of G-actin. Molecular weight 
markers are indicated in kD. (D) Left, total 
cellular lysates from mouse embryo fibro-
blasts were immunoprecipitated with an-
tiactin (Actin) or an irrelevant (ctr) anti-
body, followed by detection with the
anti-Eps8 (top) or antiactin (bottom) anti-
bodies. Right, total cellular lysates from 
Eps8 null mouse embryo fibroblasts
( / ), or from the same cells in which 
Eps8 was stably reintroduced ( /  Eps8), 
were immunoprecipitated with anti-Eps8 
(Eps8) or the preimmune (ctr) sera, fol-
lowed by detection with the anti-Eps8 
(top) or antiactin (bottom) antibodies. 
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for binding to actin or to Sos-1 failed, suggesting that the in-
tegrity of the whole domain is required for both functions.
Actin exists in a monomeric globular (G-actin) or in a
polymeric F-actin form. Therefore, GST fusion fragments of
Eps8 were tested for in vitro binding to purified F-actin and
G-actin in a high speed cosedimentation and in a low speed
centrifugation assay, respectively (Matsudaira, 1992). A sig-
nificant amount of GST-Eps8 (586–821) cosedimented
with F-actin in a concentration-dependent manner, whereas
control GST (not shown) or GST-Eps8 (586–733) (Fig. 9
B) were unable to do so. Furthermore, no binding to mono-
meric G-actin could be detected with any of the tested fu-
sion proteins (Fig. 9 C, right). Notably, under the same
conditions, efficient association between G-actin and the
COOH-terminal region of Scar2, a known G-actin binding
surface (Miki et al., 1998), could be observed (Fig. 9 C).
Thus, the effector region of Eps8 binds directly to F-actin.
However, no actin-polymerizing activity of the purified
Eps8 effector region could be detected using a pyrene-conju-
gated actin polymerization assay (Karlsson, R., and G. Scita,
personal communication). Thus, Eps8 might bind to F-actin
in a manner similar to proteins like S-nexilin (Ohtsuka et
al., 1998) or 1-afadin (Mandai et al., 1997), which are de-
void of actin-bundling properties in vitro and serve as linkers
between the actin cytoskeleton and subdomains on the
plasma membrane.
Finally, we investigated whether the Eps8–F-actin association
occurs in vivo. Native actin could be specifically coimmunopre-
Figure 10. Disruption of the actin fila-
ment meshwork by cytochalasin D 
leads to mislocalization of Eps8 and of 
the Eps8 effector domain. Quiescent 
mouse embryo fibroblasts, transfected 
with the vectors encoding various GFP-
tagged Eps8 fragments (amino acids 
boundaries are indicated on the left), 
were treated with cythocalasin D (100 
nM) for 60 min ( Cyt. D) or with vehicle 
as a control ( Cyt. D). Cells were fixed 
and GFP was detected by epifluores-
cence (green). F-actin was evidenced by 
phalloidin staining (red). Note the colo-
calization of the Eps8 full length (1–821) 
and of the Eps8 fragments containing the 
effector domain (amino acids 648–821) 
with F-actin aggregates induced by treat-
ment with cythocalasin D (yellow). 
Bar, 10  M. 
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cipitated with Eps8, whereas no association could be observed
when preimmune sera were used, or in Eps8 immunoprecipi-
tates performed on lysates from Eps8 null cells (Fig. 9 D).
The interaction in vivo between Eps8 and F-actin may
dictate the proper intracellular localization of Eps8. In this
case, disruption of the actin filaments should lead to Eps8
mislocalization. Treatment of cells with cytochalasin D, an
inhibitor of actin polymerization (Goddette and Frieden,
1986; Sampath and Pollard, 1991), caused the disruption of
the F-actin meshwork (Fig. 10). This resulted in the disrup-
tion of membrane ruffles and the scattered accumulation of
short bundles of F-actin aggregates, which colocalized (Fig.
10) with Eps8 or with those Eps8 fragments containing an
intact actin binding domain (Fig. 10). Thus, the integrity of
the F-actin meshwork is required to direct Eps8 to its proper
subcellular localization.
The localization of Eps8 and of the Eps8 effector domain
to a site of actin polymerization suggests the possibility that,
under physiological conditions, the trimeric complex Eps8–
E3b1–Sos-1 is recruited to specific sites to elicit actin re-
modelling. Thus, we determined the intracellular localiza-
tion of Sos-1 and of the adaptor molecules involved in the
formation of Sos-1–based complexes after growth factor
stimulation. Eps8, E3b1, and Sos-1, but not Grb2, rapidly
relocalized and accumulated in membrane ruffles upon
PDGFR activation (Fig. 11), pointing to an additional
mechanism through which the activity of the tricomplex is
regulated in vivo.
 
Discussion
 
We have shown previously that Eps8 is indispensable for the
activation of the small GTPase Rac (Scita et al., 1999). This
was mirrored by the detection in vivo of a tricomplex Eps8–
E3b1–Sos-1, which was shown to display Rac-GEF activity
in vitro (Scita et al., 1999). In this study, we provide evi-
dence regarding the molecular mechanisms through which
Eps8 affects the substrate specificity of Sos-1 and facilitates
targeting of a Rac-activating complex to its proper subcellu-
lar sites. We identified a COOH-terminal region that is
alone sufficient for both the actin-remodeling function and
the localization to F-actin–containing structures of Eps8.
We called this region the “effector region” of Eps8.
Several lines of evidence indicate that the effector region
of Eps8 functions as a constitutively active variant of
Eps8. First, genetic data demonstrated that the mechanism
whereby the Eps8 effector region induces ruffles requires the
activation and proper localization of Rac. Moreover, the ef-
fector region of Eps8 did not require Ras/PI3-K or Cdc42 to
induce actin remodeling. This is in agreement with our pre-
Figure 11. Eps8, E3b1, and Sos-1, but not Grb2, accumulate in PDGF-induced membrane ruffles. Serum-starved mouse embryo fibroblasts 
(ctr) were treated with 10 ng/ml of PDGF for 5 min (PDGF). Cells were then fixed and stained with antibodies indicated at the top (red), and 
with FITC-conjugated phalloidin to detect F-actin (green). Detection of Sos-1 was performed on cells which were transiently transfected with 
an expression vector coding Sos-1. Arrows point to ruffles. Bar, 10 mm. 
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vious work, which epistatically positioned Eps8 between
Ras/PI3-K and Rac (Scita et al., 1999). Biochemical evi-
dence also supported a role of the Eps8 effector region in the
activation of Rac. Its transient expression led to activation in
vivo of Rac and PAK65. Moreover, the overexpression of the
effector region of Eps8 increased the levels of Rac-specific
GEF activities in the cell by a mechanism which was shown
to be directly dependent on the presence of Sos-1 (or of Sos-
1–associated GEFs) and on the interaction between Sos-1
and the Eps8 effector region.
Thus, the effector region of Eps8 appears to signal in a
manner indistinguishable from full length Eps8, albeit in a
growth factor–independent fashion. Indeed, we showed that
the overexpression of the effector region, but not of the full
length Eps8 protein, is sufficient to elicit actin cytoskeleton
remodeling. Thus, within the context of the full length Eps8
protein, a tight regulation of the effector function must be at
play and determinants contained in the NH
 
2
 
-terminal half
of Eps8 are predicted to exert an inhibitory role. This mode
of action is remarkably reminiscent of that of Wasp and its
homologue N-Wasp, which link multiple signaling path-
ways to actin assembly. N-Wasp interacts with the Arp2/3
complex and activates the ability of the latter to nucleate ac-
tin filaments (for review see Mullins, 2000). A COOH-ter-
minal domain of N-Wasp, the VCA domain, is sufficient
when enucleated from the full length molecule to bind to
the Arp2/3 complex and activate it (Mullins, 2000). Physio-
logically, however, activation of N-Wasp occurs when the
molecule is stimulated by the proper set of upstream signals,
including active Cdc42 and PIP2. These molecules bind co-
operatively to N-Wasp and force it to adopt an open confor-
mation, which exposes the VCA domain, allowing its effec-
tor function (Rohatgi et al., 1999; Higgs and Pollard, 2000;
Prehoda et al., 2000).
In analogy to Wasp and N-Wasp, and based on our re-
sults, a model can therefore be proposed in which Eps8 that
is normally inactive in the cell is activated by upstream sig-
nals and therefore rendered competent for activation of Rac.
From our data, it appears that the key step in this series of
events is the binding of the effector region of Eps8 to Sos-1.
Indeed several activities, including Sos-1 binding, induction
of Rac-specific GEFs and activation of Rac and Rac-depen-
dent pathways, all cosegregated with the same fragment of
Eps8. Thus, it is tempting to speculate that a latent, Rac-
specific, GEF activity of Sos-1 is unmasked upon direct
binding to the effector region of Eps8. In this scenario, the
“activation” of Eps8 might correspond to a conformational
change (or functionally equivalent mechanism), which ren-
ders its effector region available for direct interaction with
Sos-1. A corollary of such a model is that full length Eps8
should not be able to bind to Sos-1 directly. Indeed, we
show in this and previous studies (Scita et al., 1999) that as-
sociation of Eps8 with Sos-1 is strictly dependent on the
presence of the scaffolding molecule E3b1 (Fig. 7C). On the
contrary, this latter molecule is not required for the interac-
tion between the effector region of Eps8 and Sos-1 (Fig. 7,
A–C), which are readily coimmunoprecipitated in vivo. To
validate this model, we are presently attempting to reconsti-
tute in vitro a Rac-specific GEF complex by using purified
E3b1–Sos-1–Eps8 or purified Sos-1–Eps8 effector region.
 
Our model also provide clues as to how the Sos-1 Rac–
specific GEF activity is regulated under physiological condi-
tions, within the context of a trimeric complex where E3b1
scaffolds together Eps8 and Sos-1. We note that the affinity
of Sos-1 for the effector region of Eps8 is rather low. Thus,
the scaffolding function of E3b1 might provide an efficient
mechanism of increasing the local concentration of the two
binders (Eps8 and Sos-1) for the purpose of achieving a stoi-
chiometry of interaction sufficient for biological output.
Under conditions of overexpression of the effector region
(but not of full length Eps8, according to our model), this
requirement might be bypassed simply by virtue of mass ac-
tion. Of course, this model does not exclude that other
events, in addition to the simple Eps8–Sos-1 interaction, are
required in vivo to activate the Rac-specific GEF function of
Sos-1. One obvious level of regulation is the one exerted by
growth factor stimulation, which might, among other ef-
fects, relieve the inhibition of Eps8. This could be achieved
by a variety of mechanisms, including tyrosine phosphoryla-
tion of Eps8 or binding of phosphoinositides to the DH-PH
domain of Sos-1 or to the PTB domain of Eps8. We are
presently investigating these possibilities.
An additional level of regulation is highlighted by our
findings of a physical direct interaction between Eps8 and
F-actin, which mirrored the in vivo colocalization of Eps8
with F-actin–containing structures. This function is also
contained within the effector region of Eps8. We could not
identify determinants within this region that would allow
the dissection of the abilities to bind to F-actin or to Sos-1.
This might be due to a high degree of overlap between the
two surfaces. In this case, single amino acid mutations might
be required to identify the residues responsible for each in-
dividual interaction. The effector region of Eps8 did not
appear to be endowed with intrinsic actin-polymerizing ac-
tivity. Thus, the most likely functional role of the Eps8–
F-actin interaction is that of directing Eps8 to sites where
actin remodeling has to occur in response to extracellular
stimuli. E3b1 and Sos-1 are also localized to F-actin–con-
taining structures after growth factor stimulation of intact
cells, and therefore interaction of Eps8 with F-actin might
dictate the relocalization of the Rac-activating trimeric com-
plex Eps8–E3b1–Sos-1 to sites where its activity is required.
 
Materials and methods
 
Expression vectors and antibodies
 
All eukaryotic expression vectors were generated in cytomegalovirus pro-
moter–based constructs (pCDNA3, pCR3; In VitroGene). Vectors encoding
for GFP fusion proteins were engineered in the pEGFP C1 plasmid (CLON-
TECH Laboratories, Inc.) by cloning the appropriate fragments, obtained by
recombinant PCR, in frame with the GFP moiety. Where indicated, epitope
tagging (either myc or HA) was obtained by recombinant PCR. Bacterial ex-
pression vectors were engineered to encode GST-fused and histidine-tagged
proteins by cloning the appropriate fragments, obtained by recombinant
PCR, in frame with GST or poly-His, respectively. All constructs were se-
quence verified. Details are available upon request. pMT2-HA-Sos-1 was a
gift of D. Bar-Sagi (State University of New York at Stony Brook, Stony
Brook, NY). Arf6T27N was provided by P. Chavrier (Chavrier P Institut Cu-
rie, Paris, France).
Antibodies (Ab) were: polyclonal anti-Eps8 (Fazioli et al., 1993), anti-
E3b1 (Biesova et al., 1997), and anti-EGFR (Di Fiore et al., 1990) sera; rab-
bit polyclonals anti–Sos-1, anti-Grb2, and anti–ERK-1, (Santa Cruz Bio-
technology, Inc.); monoclonals anti-myc and anti–v-H-Ras (Oncogene
Research Products). Monoclonals antihistidine, antiactin, antimyosin II 
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heavy chain, and the chemicals, dimethyl pimelidate dihydrochloride, cy-
tochalasin D, and wortmannin were from Sigma-Aldrich. Purified muscle
actin was purchased from Cytoskeleton.
 
Transfection procedures and indirect immunofluorescence
 
Fibroblasts, seeded on gelatin, were transfected with the indicated expres-
sion vectors using the LIPOfectamine reagent (GIBCO BRL), according to
the manufacturer’s instructions. Alternatively, nuclei of quiescent fibro-
blasts were injected with 100 ng/ml of the appropriate expression vectors.
3–6 h later, cells were processed for immunostaining. At least 100 micro-
injected cells were analyzed in each experiment for indirect immunofluo-
rescence. Cells were fixed in 4% paraformaldheyde for 10 min, permeabi-
lized in 0.1% Triton X-100 and 2% BSA for 10 min, blocked with 2% BSA
for 30 min, and then incubated with primary and secondary antibodies for
45 and 30 min, respectively. Transfected and/or microinjected cells were
detected by staining of the protein encoded by the transfected or microin-
jected cDNA. F-actin was detected by staining with rhodamine-conjugated
phalloidin (Sigma-Aldrich), used at a concentration of 6.7 U/ml (
 
 
 
0.22
 
 
 
M). Alexa red and green secondary antibodies (Molecular Probes) were
used. Where indicated, cells were treated with PDGF (10 ng/ml) or serum
(10%) for 10 min before fixation.
 
Biochemical and functional assays
 
Standard procedures of protein analysis (in vitro binding assays, immuno-
precipitations, and coimmunoprecipitations) were performed as described
(Fazioli et al., 1993). The activities of MAPK, JNK, PAK65, and the levels of
RacGTP were also measured as described (Scita et al., 1999). Whenever
indicated, treatment was performed with EGF (100 ng/ml) after serum star-
vation for the indicated lengths of time.
Assays for Rac-GEF activity were performed as described (Scita et al.,
1999). Data are the mean 
 
 
 
 SE of at least three independent experiments
performed in triplicate. Results are expressed as the [
 
3
 
H]GDP released after
20 min relative to time 0 after subtracting the background counts released
in control reactions (obtained by incubating [
 
3
 
H]GDP-loaded Rac in ex-
change buffer).
For protein identification by MALDI-MS analysis, total cellular proteins
were incubated in the presence of various immobilized GST fusion pro-
teins. Specifically bound proteins were subjected to SDS-PAGE followed
by detection with silver staining. The protein bands of interest were ex-
cised from one-dimensional polyacrylamide gels. After reduction and
alkylation, proteins were digested “in gel” for 6 h at 37
 
 
 
C with sequenc-
ing-grade trypsin (Boehringer). Samples for MALDI analysis were pre-
pared by using the “fast evaporation” method (Mann and Talbo, 1996).
Mass spectra were recorded on a Voyager-DE STR BioSpectrometry
workstation (PerSeptive Biosystems). Matrix-related ions and trypsin au-
tolysis products were used for internal calibration. The peptide mass ac-
curacy was  30 ppm (on average). The ProFound-Peptide Mapping soft-
ware (Rockefeller University edition, v4.10.5) was used to search a
nonredundant protein sequence database (searchable at the National
Center for Biotechnology Information) with a list of peptide masses. The
samples for MS/MS analysis were loaded onto a Poros R2 (PerSeptive Bio-
systems) microcolumm, desalted, and eluted into nanoelectrospray nee-
dles (Protana). Nanoelectrospray MS/MS analysis was performed on a
quadrupole time-of-fight mass spectrometer (QSTAR; PerkinElmer). The
resulting “peptide sequence tags” were used to search the nonredundant
protein sequence database.
For cosedimentation assays with F-actin, monomeric human nonmuscle
G-actin (1 mg/ml) was induced to polymerize into F-actin at 37 C for 60
min in F-buffer (5 mM Tris/HCl, pH 7.8, 1 mM ATP, 0.5 mM DTT, 0.2 mM
CaCl2, 0.2 mM MgCl2, and 100 mM KCl) (Van Etten et al., 1994). Recom-
binant, purified GST fusion proteins (2  M) were subsequently incubated
with increasing concentration of F-actin in F-buffer for 45 min at 37 C. The
mixtures were centrifuged in a TLA-100 rotor for 60 min at 100,000 g.
Equal amounts of starting material, supernatants, and pellets were solubi-
lized in loading buffer, boiled, and subjected to SDS-PAGE. Proteins were
detected by immunoblotting using anti-GST and antiactin antibodies. The
rate and the extent of actin polymerization in the presence of the Eps8 ef-
fector region was determined from the increase in fluorescence of pyrene
actin that occurs when pyrene-labeled actin polymerizes, as described
(Van Etten et al., 1994).
For Sos-1 purification, total cellular lysates from 293T cells, transfected
with HA epitope–tagged Sos-1, were immunopurified onto an affinity col-
umn obtained by cross-linking anti-HA antibodies to immobilized protein
G with dimethyl pimelidate dihydrochloride. After binding, the column
was washed with the 10-bed volumes of lysis buffer containing 0.2% SDS.
Bound Sos-1 was eluted with the peptide MYDVPDYAS, corresponding to
the HA epitope tag. Sos-1 was  90% pure, as assessed by calculating the
percentage of Sos-1 with respect to the total amount of protein. This was
determined by subjecting serial dilutions of the purified material to SDS-
PAGE followed by staining with Coomassie brilliant blue and compared
with a standard curve of BSA. Similar results were obtained by comparing
the intensity of the band corresponding to Sos-1 with the bands corre-
sponding to contaminants and/or to Sos-1 degradation products.
Online supplemental material
Video 1 and Figure S1. Quiescent mouse embryo fibroblasts, microin-
jected with expression vectors for GFP-Eps8 (648-821) were kept at 37 C
in a CO2 incubator mounted on an inverted microscope (Olympus). Images
were captured every 15 min with a coded CCD camera (Hamamatsu;
speed, 6 frames/s at 15 min intervals). GFP epifluorescence was detected
with a FITC filter set (Chromo Technology). The large fluorescent “blob”
(visible in the top half in the final frames) probably represents a GFP-Eps8
(648–821)–transfected cell undergoing apoptosis after a round of cell divi-
sion. A set of six consecutive images captured at the indicated time is also
shown. The video and figure are available at http://www.jcb.org/content/
vol154/issue5.
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